Prognostic outcomes of adjuvant chemotherapy in postoperative patients with cancer undergoing hemodialysis versus non-hemodialysis patients: a retrospective nationwide cohort study
Taisuke Ishii, Tomone Watanabe, Yuichi Ichinose, Hiroyuki Mano, Takahiro Higashi · 2026
Read Prognostic outcomes of adjuvant chemotherapy in postoperative patients with cancer undergoing hemodialysis versus non-hemodialysis patients: a retrospective nationwide cohort study by Taisuke Ishii, Tomone Watanabe, Yuichi Ichinose, Hiroyuki Mano, Takahiro Higashi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13422312.txt.
Description
Taisuke Ishii and four colleagues compare, in a 2026 nationwide Japanese study, how patients on dialysis fare with chemotherapy after cancer surgery versus similar patients not on dialysis. Doctors often soften or skip adjuvant chemotherapy for dialysis patients, fearing toxicity through failing kidneys, yet hard evidence on the trade-off was missing.
Merging the hospital cancer registry with national claims data, the study covered adults newly diagnosed between 2013 and 2015 with colorectal, stomach, breast or lung cancer. Survival analysis began ninety days after surgery, counting chemotherapy started within that window, and statistical models separated the effects of dialysis status and treatment. The authors present the work as a basis for fairer, evidence-led drug decisions in this group.
Catalog record
| CREATOR | Taisuke Ishii, Tomone Watanabe, Yuichi Ichinose, Hiroyuki Mano, Takahiro Higashi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34675 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |